Clinical Trial Update: Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab with either anthracycline-free or anthracycline-containing chemotherapy as neoadjuvant treatment for early triple-negative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: TNBC - Triple-Negative Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING